Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- Check3 days agoChange DetectedAdded Locations sections for California, District of Columbia, Florida, Georgia, Missouri, New Jersey, Texas, and Virginia and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure and the California, District of Columbia, Florida, Georgia, Missouri, New Jersey, Texas, and Virginia Locations entries from the previous revision (v3.3.2).SummaryDifference0.5%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a note clarifying that PubMed-published articles are auto-filled from PubMed and may not be about the study; Revision: v3.3.2 updated from the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA site-wide government funding/operational status notice was removed from the page. This change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedNo significant content changes detected for the Study Details page (NCT02429791); minor visual/formatting differences do not affect core information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check83 days agoChange Detected- Added a prominent operations/status notice and a link to cc.nih.gov, plus a reminder about government updates; - Updated version from v3.1.0 to v3.2.0.SummaryDifference0.9%

- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.